Clinical Trial Update: Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma [Phase 2]

View source ↗

Summary

Phase II study of DCVAC/OvCa with carboplatin and gemcitabine in relapsed platinum-sensitive epithelial ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Ovarian Epithelial Cancer
• Ovarian Neoplasms

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DCVAC/OvCa
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: SOTIO a.s. | Conditions: Ovarian Neoplasms, Ovarian Cancer (OvCa) | Phase 2 | Status: COMPLETED